Chief executive Denis Corin will give a presentation on Monday (March 12), while he will also be available for one-on-one investor meetings on Monday and Tuesday (March 13).
View full QBIO profile View Profile
The broker says the cancer treatment developer could potentially take the entire share of the growth market from ageing cyclotron companies
"The formation of ProBiotix Health and appointment of Adam Reynolds as chairman continues a successful strategy of building value in each division which is materialised by forming separate legal entities and taking them to a public listing,” said chief executive Stephen O’Hara
Sativa Investments has taken a big step towards becoming the UK's first seed to consumer medicinal cannabis business